Header cover image

Dutch (AEX) Healthcare Sector Analysis

UpdatedApr 13, 2024
DataAggregated Company Financials
  • 7D2.0%
  • 3M-14.3%
  • 1Y12.8%
  • YTD-12.4%

Over the last 7 days, the Healthcare industry has risen 2.0%, driven by gains from Koninklijke Philips of 2.6%. In the last 12 months, the industry was up 13%. Earnings are forecast to grow by 56% annually.

Sector Valuation and Performance

Has the Dutch Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 14 Apr 2024€20.0b€18.6b-€570,261,198.13n/a-35x1.1x
Tue, 12 Mar 2024€20.7b€18.6b-€576,097,003.81n/a-35.9x1.1x
Thu, 08 Feb 2024€20.6b€18.9b-€725,428,372.99n/a-28.4x1.1x
Sat, 06 Jan 2024€23.2b€19.3b-€877,488,424.00n/a-26.5x1.2x
Mon, 04 Dec 2023€20.5b€19.3b-€878,032,741.00n/a-23.3x1.1x
Wed, 01 Nov 2023€19.5b€19.3b-€881,666,786.00n/a-22.1x1x
Fri, 29 Sep 2023€20.7b€19.1b-€2,302,765,735.00n/a-9x1.1x
Sun, 27 Aug 2023€22.3b€19.1b-€2,426,726,296.00n/a-9.2x1.2x
Tue, 25 Jul 2023€21.8b€18.8b-€2,533,193,606.00n/a-8.6x1.2x
Thu, 22 Jun 2023€20.7b€18.8b-€2,534,142,348.00n/a-8.2x1.1x
Sat, 20 May 2023€20.6b€18.8b-€2,517,890,391.0059.3x-8.2x1.1x
Mon, 17 Apr 2023€17.9b€18.5b-€2,025,182,947.0053.7x-8.8x1x
Wed, 15 Mar 2023€17.7b€18.5b-€2,017,051,147.0025.1x-8.8x1x
Fri, 10 Feb 2023€18.1b€18.6b-€1,792,577,472.00234.4x-10.1x1x
Sun, 08 Jan 2023€17.7b€18.1b-€1,535,645,258.00259.3x-11.5x1x
Tue, 06 Dec 2022€16.6b€18.1b-€1,539,345,144.00235.9x-10.8x0.9x
Thu, 03 Nov 2022€15.9b€18.1b-€1,623,821,123.0023.5x-9.8x0.9x
Sat, 01 Oct 2022€18.3b€17.9b€135.9m33.9x135x1x
Mon, 29 Aug 2022€19.8b€17.9b€227.7m36.3x86.9x1.1x
Wed, 27 Jul 2022€23.8b€17.9b€171.6m47.2x138.7x1.3x
Fri, 24 Jun 2022€22.4b€18.0b€262.0m40.4x85.6x1.2x
Sun, 22 May 2022€25.6b€18.0b€260.6m44.9x98.3x1.4x
Tue, 19 Apr 2022€28.5b€17.8b€485.8m38.6x58.6x1.6x
Thu, 17 Mar 2022€29.7b€17.8b€490.1m34.3x60.7x1.7x
Sat, 12 Feb 2022€30.7b€17.9b€414.5m36.3x74.2x1.7x
Mon, 10 Jan 2022€32.2b€20.4b€979.5m25.6x32.9x1.6x
Wed, 08 Dec 2021€31.3b€20.4b€979.5m23.6x31.9x1.5x
Fri, 05 Nov 2021€41.2b€20.4b€952.5m29.5x43.3x2x
Sun, 03 Oct 2021€38.3b€20.7b€804.3m26.6x47.7x1.9x
Tue, 31 Aug 2021€39.9b€20.7b€808.4m28.5x49.4x1.9x
Wed, 07 Jul 2021€43.1b€20.7b€808.4m30.4x53.4x2.1x
Price to Earnings Ratio


Total Market Cap: €47.7bTotal Earnings: €890.6mTotal Revenue: €20.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Dutch Healthcare Sector Price to Earnings3Y Average 26.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Dutch Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 1.4x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 2.9% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the Dutch Healthcare sector?

NL Market-0.55%
Medical Equipment2.60%
Healthcare Services0%
Life Sciences0%
Industry PE
    Forecasted Growth
    • Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 66% over the next 5 years.
    • In contrast, the Biotech industry is expected to see its earnings decline by 9.8% per year over the next few years.

    Top Stock Gainers and Losers

    Which companies have driven the market over the last 7 days?

    CompanyLast Price7D1YValuation
    PHIA Koninklijke Philips€19.122.6%
    PHARM Pharming Group€1.011.1%
    Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

    Latest News

















    Pharming Group







    Vivoryon Therapeutics